These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 4563156)

  • 1. A controlled study of prindolol (Visken) in hypertension.
    Thorpe P
    Med J Aust; 1972 Aug; 2(6):306-9. PubMed ID: 4563156
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of hypertension with a combination of prindolol and clopamide (author's transl)].
    Gábor G; Jávor T; Szám I; Török E
    MMW Munch Med Wochenschr; 1975 Nov; 117(46):1853-6. PubMed ID: 811982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of hypertension with a new beta-blocking agent, pindolol (Visken).
    Persson I; Ulrich J
    Eur J Clin Pharmacol; 1973 Dec; 6(4):217-9. PubMed ID: 4591149
    [No Abstract]   [Full Text] [Related]  

  • 4. [Use of the adrenergic beta receptor blockader, visken, (prindolol) in arterial hypertension].
    Savenkov PM; Doshitsin VL; Grudtsyn GV
    Kardiologiia; 1977 Oct; 17(10):62-6. PubMed ID: 599799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Use of Visken-15 for treating hypertension].
    Erina EV; Megrelishvili RI; Pushkar' IuT; Beliakova EV; Lediashova GA
    Kardiologiia; 1979 Mar; 19(3):46-52. PubMed ID: 372668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Double-blind factorial trial of prindolol and hydrochlorothiazide in hypertension.
    Chalmers JP; Korner PI; Tiller DJ; Bune AJ; Steiner JD; West MJ; Wing LM; Uther JF
    Med J Aust; 1976 May; 1(18):650-3. PubMed ID: 781495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination therapy of essential hypertension with pindolol (Visken) and hydralazine.
    Persson I
    Adv Clin Pharmacol; 1976; 11():1114-8. PubMed ID: 802071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prindolol (Visken) and alprenolol (Aptin) in angina pectoris: a comparative clinical study with special reference to ergometer working capacity tests.
    Bjerle P; Jacobsson KA
    Curr Ther Res Clin Exp; 1974 Feb; 16(2):101-16. PubMed ID: 4218804
    [No Abstract]   [Full Text] [Related]  

  • 9. Pindolol in hypertension: a double-blind trial.
    Feltham PM; Watson OF; Peel JS; Dunlop DJ; Turner AS
    N Z Med J; 1972 Sep; 76(484):167-71. PubMed ID: 4564997
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of coexistent angina pectoris and hypertension with prindolol.
    Leary WP; Asmal AC
    S Afr Med J; 1975 Jan; 49(1):11-2. PubMed ID: 803324
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of hypertension with a new beta-adrenergic blocking agent, pindolol (Viskén)].
    Persson I; Ulrich J
    Ugeskr Laeger; 1973 May; 135(20):968-70. PubMed ID: 4755952
    [No Abstract]   [Full Text] [Related]  

  • 12. Combination therapy of essential hypertension with pindolol (Visken) and hydralazine.
    Persson I
    Eur J Clin Pharmacol; 1975 Dec; 9(2-3):91-3. PubMed ID: 786690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of hypertension with the beta-receptor-antagonist pindolol (Viskèn). A comparison with chlorthalidone (Hygroton)].
    Schaffalitzky de Muckadel ; Gyntelberg F
    Ugeskr Laeger; 1973 May; 135(20):971-4. PubMed ID: 4585570
    [No Abstract]   [Full Text] [Related]  

  • 14. Adrenergic beta-receptor blockade in essential hypertension: a comparison between pindolol (Visken) and propranolol (Inderal).
    Bjerle P; Jacobsson KA; Agert G
    Curr Ther Res Clin Exp; 1975 Sep; 18(3):387-94. PubMed ID: 241607
    [No Abstract]   [Full Text] [Related]  

  • 15. A comparison of propranolol and prindolol in the treatment of essential hypertension.
    Beaton GR; Rosendorff C; Kramer R; Simpson RD
    Curr Ther Res Clin Exp; 1974 Apr; 16(4):268-74. PubMed ID: 4208340
    [No Abstract]   [Full Text] [Related]  

  • 16. The antihypertensive effect of pindolol (Visken) alone and combined with clopamide (Brinaldix).
    Persson I
    Eur J Clin Pharmacol; 1977 Jul; 11(6):419-21. PubMed ID: 330169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of efficacy and safety of pindolol and alpha-methyldopa in treatment of mild to moderate hypertension: results of a double-blind evaluative study.
    Beanlands DS; Allard PP; Wilson M; Orbeck KW; Helman AB; Lefebvre R
    Clin Invest Med; 1978; 1(3-4):139-45. PubMed ID: 391453
    [No Abstract]   [Full Text] [Related]  

  • 18. [Controlled study of high blood pressure treatment using betablocker Visken (author's transl)].
    Ripka O; Linhartová J; Jarolím M; Okrouhlík B; Chvatíková J
    Sb Lek; 1975 Oct; 77(10):294-7. PubMed ID: 1101360
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of pindolol (Visken) on blood pressure and plasma renin activity in various forms of hypertension].
    Werning C; Vetter H
    Adv Clin Pharmacol; 1976; 11():54-60. PubMed ID: 1032571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of pindolol (Visken) on plasma and blood volume in men with primary arterial hypertension].
    Wyrzykowski B; Suchecka-Rachoń K
    Pol Tyg Lek; 1985 Sep; 40(38):1083-6. PubMed ID: 3906604
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.